Health Bulletin 10/November/2021

Published On 2021-11-10 16:15 GMT   |   Update On 2021-11-11 06:10 GMT
Advertisement

Here are the Top Health Stories of the day

Doctor does not remove healthy appendix, still directed to pay compensation

In a judgment that may raise many eyebrows across the medical fraternity, a Gujarat based doctor has recently been directed to pay compensation to a patient as he did not remove a healthy appendix.

The case was that of an open and shut surgery, where when the doctor put the patient under knife found that the appendix was not inflamed and hence decided not to remove it.

Advertisement

For more details, check out the full story on the link below:

Doctor Does Not Remove Healthy Appendix, Still Directed To Pay Compensation


Ladakh's first medical college set to begin academic session next year

With an aim to commence the classes in the first medical college of Ladakh from 2022, the Ladakh Government has ramped up the work for completion of the pre-fabricated structures of the institute.

The directions regarding this have been given to the officials during a meeting chaired by the Principal Secretary (Health and Medical Education Department) Dr Pawan Kotwal, who directed officials to ensure completion of pre-fabricated structures for the academic block of the new medical college in Leh, adds PTI.

For more details, check out the full story on the link below:

Ladakh's First Medical College To Start Admissions From Next Year


MBBS counselling will begin once Health Ministry releases NEET UG list


NEET PG 2021: SC allows OCI candidates to appear in General Category Counselling

 In an enormous relief to all the eligible candidates belonging to the Overseas Citizens of India (OCI), the Supreme Court has allowed them to participate in the general category of NEET and NEET PG counselling for the 2021-22 academic year MBBS, BDS, MD, MS and MDS admissions.

This has come as interim relief to the OCI petitioners to participate in the NEET 2021 general category counselling considering the notification that was earlier issued by the Ministry of Home Affairs (MHA) had insisted they be treated at par with NRIs only.

For more details, check out the full story on the link below:

NEET, NEET PG 2021: SC Allows OCI Candidates To Appear In General Category Counselling


Govt to amend New Drugs and Clinical Trials Rules to add cell derived products as new drugs

Through a recent notification, in order to amend the New Drugs and Clinical Trials Rules, 2019, the Ministry of Health and Family Welfare has issued a draft suggesting to add cell-derived products under the definition of a new drug.

Cell-based human medicinal products (CBMPs) may contain autologous or allogeneic cells, and may or may not include genetically modified cells, as well as cells that have been linked with a device, a scaffold, or a mesh.

For more details, check out the full story on the link below:

Govt To Amend New Drugs And Clinical Trials Rules To Add Cell Derived Products As New Drugs

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News